Atlas Trials

Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C

Clinical trial NCT02612129 · COMPLETED

Trial details

NCT number
NCT02612129
Sponsor
ZevraDenmark
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Niemann-Pick Disease, Type C
Start date
2016-06-14
Primary completion
2018-06-25
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.